News & Updates
Filter by Specialty:
Signs of heavy menstrual bleeding often missed; standardized criteria for assessment needed
Healthcare professionals (HCPs) and women themselves may overlook the signs of heavy menstrual bleeding, with most HCPs failing to recognize the key indicators for bleeding disorders and perform assessments for patients with heavy menstrual bleeding, according to a study presented at ASH 2022.
Signs of heavy menstrual bleeding often missed; standardized criteria for assessment needed
20 Jan 2023
TNFα antagonists, non-TNF biologics both safe for treating IBD in cancer patients
Tumour necrosis factor (TNF)-α antagonists show comparable safety as non-TNF biologics in the treatment of inflammatory bowel disease (IBD) in patients with active or recent cancer, as shown in a study.
TNFα antagonists, non-TNF biologics both safe for treating IBD in cancer patients
20 Jan 2023
POSEIDON: Dual ICIs plus chemo up survival in first-line mNSCLC
POSEIDON: Dual ICIs plus chemo up survival in first-line mNSCLC
20 Jan 2023
Total diet replacement shows promise for difficult-to-treat asthma
A low-calorie total diet replacement program (Counterweight-Plus) is safe and improves asthma control and quality of life in patients with difficult-to-treat asthma and obesity, according to 16-week data from a recent study.
Total diet replacement shows promise for difficult-to-treat asthma
19 Jan 2023
MRI- vs CT- guided radiotherapy for localized prostate cancer linked to lower toxicity, symptom burden
Magnetic resonance imaging (MRI) guidance in stereotactic body radiotherapy (SBRT) for prostate cancer offers significant advantage over computed tomography (CT) guidance, with lower physician-scored toxic effects and patient-reported symptom burden, according to the results of the phase III MIRAGE* study.